Relay Therapeutics focuses on selective small-molecule inhibitors, with RLY-2608 showing promise in breast cancer and a solid cash position lasting into 2027. Financial stability is strong, but zero ...

Relay Therapeutics leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety and efficacy in advanced breast cancer. RLY-2608’s phase 1/2 trial data demonstrates higher response rates ...

Cambridge, Massachusetts-based Relay is acquiring privately held ZebiAI for $85 million. According to deal terms announced Friday, Relay is paying $20 million cash up front and $65 million in the ...

Rae Hodge was a senior editor at CNET. She led CNET's coverage of privacy and cybersecurity tools from July 2019 to January 2023. As a data-driven investigative journalist on the software and services ...

I would like to turn on my car's heated seats over a mobile/cellular network using my iPhone, and I'm trying to figure out the simplest path. I know very little beyond that goal, but I know that RF, ...

The 'Rogue One' star joked to 'Andor' creator Tony Gilroy that he should get a consolation prize for not being on the show: "Does that mean I'm getting a Bodhi Rook standalone movie?" By Brian Davids ...

The actor plays a fixer who brokers deals between whistleblowers and corporations in this gritty drama, also starring Lily James and Sam Worthington. By Lovia Gyarkye Arts & Culture Critic The film ...